BryanPSchneiderMD

PubMed

• A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset.
  Tinoco Suarez, G. R., Tinoco Suarez, G. R., Tinoco Suarez, G. R., Tinoco Suarez, G. R., Wang, C., Ma, A., Li, Y., McNutt, M., Zhang, S., Zhu, J., Hoyd, R., Wheeler, C....> ;Cancer Research Communications. 2024 Feb 5
• Molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early-stage breast cancer.
  Seibert, T., Shi, L., Althouse, S., Hoffman, R., Russ, K., Altherr, C., Warden, S., Guise, T., Coggan, A., Schneider, B., Ballinger, T.> ;Scientific Reports. 2024 Jan 10
• 1 citations
  "How is it going to help?": Exploring Black breast cancer patients' questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy.
  Katharine J Head, Lisa R Hayes, Nadia E Miller, Safia Shakil, Casey L Bales, Bryan P Schneider> ;PEC Innovation. 2023 Dec 1
• Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.
  Zhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, Tao Yu, Yujing Li, Zheng Ao, Sheng Liu, Lu Zhang, Yang Yang, Haniyeh Eyvani, Mary L Cox, Xiyu Wang, Xiaoming He, G...> ;Nature Biomedical Engineering. 2023 Aug 30
• 2 citations
  Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic Development.
  Timothy A Yap, Zsofia K Stadler, Leigh Anne Stout, Bryan P Schneider> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jun 1
• Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breas...
  Maryam Lustberg, Xuan Wu, Juan Luis Fernández-Martínez, Enrique J de Andrés-Galiana, Santosh Philips, Jeffrey Leibowitz, Bryan Schneider, Stephen Sonis> ;Supportive Care in Cancer. 2023 Feb 21
• 4 citations
  Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
  Fatemeh Ardeshir-Larijani, Bryan P Schneider, Sandra K Althouse, Milan Radovich, Ashiq Masood, Fabiana Perna, Huda Salman, Patrick J Loehrer> ;JCO Precision Oncology. 2023 Feb 1
• Identification of a SNP cluster associated with taxane-induced peripheral neuropathy risk in patients being treated for breast cancer using GWAS data derived from a la...
  Maryam Lustberg, Xuan Wu, Juan Luis Fernández-Martínez, Enrique J de Andrés-Galiana, Santosh Philips, Jeffrey Leibowitz, Bryan Schneider, Stephen Sonis> ;Supportive Care in Cancer. 2023 Jan 28
• 2 citations
  Computational pharmacogenotype extraction from clinical next-generation sequencing.
  Tyler Shugg, Reynold C Ly, Wilberforce Osei, Elizabeth J Rowe, Caitlin A Granfield, Ty C Lynnes, Elizabeth B Medeiros, Jennelle C Hodge, Amy M Breman, Bryan P Schneide...> ;Frontiers in Oncology. 2023 Jan 1
• 2 citations
  A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes.
  Xi Wu, Fei Shen, Guanglong Jiang, Gloria Xue, Santosh Philips, Laura Gardner, Geneva Cunningham, Casey Bales, Erica Cantor, Bryan Paul Schneider> ;Nature Communications. 2022 Nov 22
• 7 citations
  Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells.
  Erica L Cantor, Fei Shen, Guanglong Jiang, Zhiyong Tan, Geneva M Cunningham, Xi Wu, Santosh Philips, Bryan P Schneider> ;Scientific Reports. 2022 Sep 23
• 4 citations
  Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer.
  Milan Radovich, Jeffrey P Solzak, Chao J Wang, Bradley A Hancock, Sunil Badve, Sandra K Althouse, Steven M Bray, Anna Maria V Storniolo, Tarah J Ballinger, Bryan P Sch...> ;Clinical Cancer Research. 2022 Aug 2
• Reply to K. Nozawa et al.
  Bryan P Schneider, Tarah J Ballinger, Guanglong Jiang, Fei Shen, Nawal Kassem, Kathy D Miller> ;Journal of Clinical Oncology. 2022 Jun 10
• 6 citations
  Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing.
  Reynold C Ly, Tyler Shugg, Ryan Ratcliff, Wilberforce Osei, Ty C Lynnes, Victoria M Pratt, Bryan P Schneider, Milan Radovich, Steven M Bray, Benjamin A Salisbury, Baij...> ;The Journal of Molecular Diagnostics. 2022 Jun 1
• 4 citations
  Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
  Tarah J Ballinger, Guanglong Jiang, Fei Shen, Kathy D Miller, George W Sledge Jr, Bryan P Schneider> ;Cancer. 2022 Jun 1
• 8 citations
  Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TB...
  Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau Dang, Denise A Yardley, Steven J Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani...> ;NPJ Breast Cancer. 2022 Feb 16
• 4 citations
  Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast C...
  Shoshana M Rosenberg, Anne O'Neill, Karen Sepucha, Kathy D Miller, Chau T Dang, Donald W Northfelt, George W Sledge, Bryan P Schneider, Ann H Partridge> ;JAMA Network Open. 2022 Feb 1
• 5 citations
  Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers.
  Tyler Shugg, Reynold C Ly, Elizabeth J Rowe, Santosh Philips, Mustafa A Hyder, Milan Radovich, Marc B Rosenman, Victoria M Pratt, John T Callaghan, Zeruesenay Desta, B...> ;JCO Precision Oncology. 2022 Feb 1
• 13 citations
  BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breas...
  Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, Fei Shen, Christopher Chitambar, Rita Nanda, Carla Falkson, Filipa C Lynce, Christopher Gallagher, Claudine Isaa...> ;Journal of Clinical Oncology. 2022 Feb 1
• 4 citations
  The impact of SBF2 on taxane-induced peripheral neuropathy.
  Geneva M Cunningham, Fei Shen, Xi Wu, Erica L Cantor, Laura Gardner, Santosh Philips, Guanglong Jiang, Casey L Bales, Zhiyong Tan, Yunlong Liu, Jun Wan, Jill C Fehrenb...> ;Plos Genetics. 2022 Jan 1
• Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer.
  Elizabeth J Rowe, Tyler Shugg, Reynold C Ly, Santosh Philips, Marc B Rosenman, John T Callaghan, Milan Radovich, Brian R Overholser, Bryan P Schneider, James E Tisdale...> ;Frontiers in Cardiovascular Medicine. 2022 Jan 1
• 5 citations
  Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
  Julia C F Quintanilha, Jin Wang, Alexander B. Sibley, Chen Jiang, Amy S. Etheridge, Fei Shen, Guanglong Jiang, Flora Mulkey, Jai N. Patel, Daniel L. Hertz, Elizabeth C...> ;British Journal of Cancer. 2021 Dec 1
• 16 citations
  Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC.
  Sagar Sardesai, Alexandra Thomas, Christopher Gallagher, Filipa Lynce, Yvonne L. Ottaviano, Tarah J. Ballinger, Bryan P. Schneider, Anna Maria Storniolo, Amber Bauchle...> ;Clinical Cancer Research. 2021 Nov 1
• 34 citations
  An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity
  Zhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, Tao Yu, Yujing Li, Zheng Ao, Sheng Liu, Lu Zhang, Yang Yang, Haniyeh Eyvani, Mary L. Cox, Xiyu Wang, Xiaoming He, ...> ;Nature Biomedical Engineering. 2021 Nov 1
• 7 citations
  Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
  Julia C F Quintanilha, Jin Wang, Alexander B. Sibley, Chen Jiang, Amy S. Etheridge, Fei Shen, Guanglong Jiang, Flora Mulkey, Jai N. Patel, Daniel L. Hertz, Elizabeth C...> ;British Journal of Cancer. 2021 Oct 6
• Join now to see all

Journal Articles

• Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast Cancer  
  Rita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology
• Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)  
  Hope S Rugo, Bryan P Schneider, Alan Venook, Clinical Cancer Research
• Survival in Metastatic Recurrent Breast Cancer: No Evidence for Improvement Due to Metastastic Therapies Over the Past Three Decades  
  Tevaarwerk A, Gray R, Schneider BP, Smith ML, Wagner L, Fetting J, Davidson N, Tevaarwerk A, Gray R, Schneider BP, Smith ML, Wagner L, Fetting J, Davidson N,, Cancer, 3/15/2013
• Prognostic and predictive value of tumor VEGF gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 21...  
  Schneider BP, Gray RJ, Radovich M, Shen F, Vance G, Li L, Jiang G, Miller KD, Gralow JR, Dickler MN, Cobleigh, Perez EA, Shenkier TN, , Sledge GW, Sparano JA, Davidson..., Clinical Cancer Research, 1/22/2013
• Functional microRNAs in Alzheimer’s disease and cancer: Differential regulation of common mechanisms and pathways  
  Holohan KN, Lahiri DK, Schneider BP, Foroud T, Saykin AJ, Frontiers in Non-Coding RNA, 1/1/2013
• Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment  
  Schneider BP, Shen F, Miller KD, Lancet Oncology, 10/1/2012
• A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors  
  Jhaveri K, Miller KD, Rosen L, Schneider BP, Chap L, Hannah A, Zhong Z, Ma W, Hudis C, Modi S, Clinical Cancer Research, 1/1/2012
• Anti–Vascular Endothelial Growth Factor Therapy for Breast Cancer: Can We Pick the Winners?  
  Schneider B and Sledge G, Journal of Clinical Oncology, 1/1/2011
• Cancer associated alteration of pericentromeric heterochromatin may contribute to chromosome instability  
  Slee R, Steiner CM, Herbert B-S, Vance GH, Hickey RJ, Schwarz T, Christan S, Radovich M, Schneider BP, Schindelhauer D and Grimes BR, Oncogene, 1/1/2011
• Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer  
  Schneider BP, Zhao F, Wang M, Stearns V, Martino S, Jones V, Perez EA, Saphner, TA, Wolff AC, Sledge GW, Wood W, Davidson NE, and Sparano JA, Journal of Clinical Oncology, 1/1/2011
• Compliance differences between patients with breast cancer in university and county hospitals  
  Komenaka I, Pennington R, Schneider B,. Hsu C, Norton L, Clare S, Zork N, Goulet R, Clinical Breast Cancer, 10/1/2010
• Evaluating the role of serotonin on neuropsychological function after breast cancer using acute tryptophan depletion  
  Von Ah D, Skaar R, Unverzagt F, Yu M, Wu J, Schneider B, Storniolo A, Moser L, Ryker K, Milata J, & Carpenter J, Biological Research for Nurses, 4/1/2010
• Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology Group  
  Jalal S, Bedano P, Einhorn L, Bhatia S, Ansari R, Bechar N, Koneru K, Govindan R, Wu J, Yu M, Schneider B, Hanna N, Journal of Thoracic Oncology 5, 1/1/2010
• The Role of Vascular Endothelial Growth Factor Genetic Variability in Cancer  
  Schneider B, Radovich M, & Miller K, Clinical Cancer Res, 1/1/2009
• Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?  
  Schneider B, Sledge G, Breast Cancer Research, 1/1/2009
• Intrinsic subtype-associated changes in the plasma proteome in breast cancer  
  Nakshatri H, Qi G, You J, Kerry B, Schneider B, Zon R, Buck C, Regnier F, Wang M, Proteomics Clinical Applications, 1/1/2009
• A phase I dose escalation and pharmacokinetic study of Vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors  
  Chiorean E, Malireddy S, Younger A, Jones D, Waddell M, Sloop M, Yu M, Hall S, Schneider B, & Sweeney C, Cancer Chemotherapy and Pharmacology, 1/1/2009
• Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy  
  Otte J, Flockhart D, Hayes D, Storniolo A, Stearns V, Schneider B, Henry N, Azzouz F, Nguyen A, Lemler S, Hayden J, Jeter S, Wright L, Carpenter JS, Menopause, 1/1/2009
• Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion  
  Carpenter J, Yu M, Wu J, Von Ah D, Milata J, Otte J, Johns S, Schneider B, Storniolo A, Salomon R, Desta Z, Cao D, Jin Y, Philips S, Skaar T, Menopause, 1/1/2009
• A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors  
  Kesler K, Rieger K, Hammoud Z, Kruter L, Perkins S, Turrentine M, Schneider B, Einhorn L, Brown J, Annals of Thoracic Surgery, 1/1/2008
• Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compare...  
  Schneider B, Wang M, Radovich M, Sledge G, Badve S, Thor A, Flockhart D, Hancock B, Davidson N, and Miller K, Journal of Clinical Oncology, 1/1/2008
• Triple negative breast cancer: risk factors to potential targets  
  Schneider B, Winer E, Foulkes W, Garber J, Perou C, Richardson A, Sledge G, Carey L, Clinical Cancer Research, 1/1/2008
• Is the blood-brain barrier relevant in metastatic germ cell tumor?  
  Azar J, Schneider B, Einhorn L, International Journal of Radiation Oncology, Biology, Physics, 1/1/2007
• A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alfa2b in patients with solid tumors  
  Schneider B, Fukunaga A, Murry D, Yoder C, Fife K, Foster A, Rosenberg L, Kelich S, Li L, and Sweeney C, Cancer Chemotherapy and Pharmacology, 1/1/2007
• Drug Insight: VEGF as a therapeutic target for breast cancer  
  Schneider B and Sledge G, Nature Clinical Practice Oncology, 1/1/2007
• Join now to see all

Lectures

• How to Recognize Germline Mutations Found During Somatic Tumor Testing 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018